Xencor, Inc. (XNCR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vir Biotechnology, Inc.

Rhythm Pharmaceuticals, Inc.

Maravai Lifesciences Holdings, Inc.

Merus NV

BioCryst Pharmaceuticals, Inc.

Xencor, Inc.

AbCellera Biologics, Inc.

Arcus Biosciences, Inc.

Summit Therapeutics, Inc.

Spyre Therapeutics, Inc.

Zentalis Pharmaceuticals, Inc.

Why is Xencor, Inc. ?

Poor Management Efficiency with a low ROE of 0.66%

The company has been able to generate a Return on Equity (avg) of 0.66% signifying low profitability per unit of shareholders funds

Negative results in Jun 26

NET PROFIT(HY) At USD -115.98 MM has Grown at -47.88%
NET SALES(HY) At USD 55.74 MM has Grown at -26.99%
OPERATING CASH FLOW(Y) Lowest at USD -205.82 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 184.29%, its profits have risen by 20.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Xencor, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Xencor, Inc.

184.29%

-0.07

68.69%

S&P 500

22.36%

1.69

13.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.47%

EBIT Growth (5y)

-179.18%

EBIT to Interest (avg)

-35.77

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.49

Sales to Capital Employed (avg)

0.18

Tax Ratio

0.95%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.59%

ROE (avg)

0.66%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.32

EV to EBIT

-2.33

EV to EBITDA

-2.47

EV to Capital Employed

1.96

EV to Sales

3.29

PEG Ratio

Dividend Yield

ROCE (Latest)

-84.18%

ROE (Latest)

-27.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

NET PROFIT(HY)

Higher at USD -115.98 MM

RAW MATERIAL COST(Y)

Fallen by -1.42% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -56.9 %

NET SALES(Q)

Highest at USD 51.22 MM

OPERATING PROFIT MARGIN(Q)

Highest at -67.61 %

-19What is not working for the Company

NET PROFIT(HY)

At USD -115.98 MM has Grown at -47.88%

NET SALES(HY)

At USD 55.74 MM has Grown at -26.99%

OPERATING CASH FLOW(Y)

Lowest at USD -205.82 MM

INTEREST(Q)

At USD 7.35 MM has Grown at 56.43%

CASH AND EQV(HY)

Lowest at USD 901.4 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.34 times

Here's what is working for Xencor, Inc.

Net Sales

At USD 51.22 MM has Grown at 110.44%

over average net sales of the previous four periods of USD 24.34 MM

MOJO Watch

Near term sales trend is extremely positive

Net Sales (USD MM)

Net Profit

Higher at USD -115.98 MM

than preceding 12 month period ended Jun 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales

Highest at USD 51.22 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Operating Profit Margin

Highest at -67.61 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Debt-Equity Ratio

Lowest at -56.9 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -1.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Xencor, Inc.

Net Profit

At USD -115.98 MM has Grown at -47.88%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 7.35 MM has Grown at 56.43%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -205.82 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Cash and Eqv

Lowest at USD 901.4 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio

Lowest at 2.34 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio